News
Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at MIT
June 28, 2010 10:34 am | by Bio-Medicine.Org | CommentsRARITAN, N.J. , June 28 /- Ortho-McNeil-Janssen Pharmaceuticals, Inc. today announced the signing of a five-year collaboration agreement with the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology . Called TRANSCEND, the...
Abbott Receives FDA Clearance for Molecular Diagnostic Test for Detection of Chlamydia and Gonorrhea Infections
June 28, 2010 10:34 am | by Bio-Medicine.Org | CommentsDES PLAINES, Ill. , June 28 /- Abbott (NYSE: ABT ) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually...
Global Acute Coronary Syndrome Industry
June 28, 2010 10:34 am | by Bio-Medicine.Org | CommentsNEW YORK , June 28 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Acute Coronary Syndrome industry http://www.reportlinker.com/p0197235/Global-Acute-Coronary-Syndrome-indu... This report analyzes the globa...
Studies of women's attitudes to 'social egg freezing' find reasons differ with age
June 28, 2010 8:34 am | by EurekAlert | Comments(European Society of Human Reproduction and Embryology) Women of different ages differ in their reasons for wishing to undergo egg freezing, show two studies presented to the 26th annual meeting of the European Society of Human Reproduction and Embryology today.
Endometriosis has a significant effect on women's work productivity, first
June 28, 2010 8:34 am | by EurekAlert | Comments(European Society of Human Reproduction and Embryology) The first worldwide study of the societal impact of endometriosis has found a significant loss of work productivity among those women who suffer from the condition.
Overweight women undertaking ART twice as likely to miscarry as their slimmer counterparts
June 28, 2010 8:34 am | by EurekAlert | Comments(European Society of Human Reproduction and Embryology) Being overweight leads to a greater risk of miscarriage for patients undergoing assisted reproductive technology, the 26th annual conference of the European Society of Human Reproduction and Embryology heard today. Dr. Vivian...
Screening for transmissible disease in ART patients not necessary at each donation
June 28, 2010 8:34 am | by EurekAlert | Comments(European Society of Human Reproduction and Embryology) European legislation that requires all couples undergoing assisted reproduction treatment to be screened for HIV and hepatitis at the time of every sperm or egg donation is unnecessary, expensive, and potentially distressing...
Forma Therapeutics, Emerald BioStructures partner over drug development
June 28, 2010 8:33 am | by Mass High Tech: The Journal of New England Technology | CommentsCambridge small-molecule therapeutics developer Forma Therapeutics Inc. has partnered with Emerald BioStructures for the structure-based development of potential cancer drug targets.
Memories are made of this
June 28, 2010 7:35 am | by EurekAlert | Comments(University of Leicester) A new Wellcome Trust-funded study led by University of Leicester uncovers the key to how we learn and remember.
Tianyin Promotes its Flagship Product Portfolio at the 45th 2010 National New Special Drugs Trade Fair in July at Beijing
June 28, 2010 7:32 am | by Bio-Medicine.Org | CommentsCHENGDU, China , June 28 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical (NYSE Amex: TPI ), a biopharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine and branded generics will exhibit and promote its flagship product...
International study identifies 12 new genetic risk factors for type 2 diabetes
June 28, 2010 6:38 am | by EurekAlert | Comments(Helmholtz Zentrum München - German Research Center for Environmental Health) An international consortium including Helmholtz Zentrum Muenchen and the German Diabetes Center, Duesseldorf, has identified 12 new gene variants which impact the individual's risk of developing type 2...
Partners CIO Glaser heads to Siemens
June 28, 2010 6:38 am | by Mass High Tech: The Journal of New England Technology | CommentsSiemens Healthcare has hired away Partners Healthcare CIO John Glaser to head up its global healthcare IT business. The job change ends Glaser's tenure as CIO at Partners, which had lasted 15 years.
Upsher-Smith Laboratories Adds ITI-111 (Nasal Midazolam) to CNS Development Pipeline
June 28, 2010 6:37 am | by Bio-Medicine.Org | CommentsMAPLE GROVE, Minn. , June 28 /- Upsher-Smith Laboratories, Inc. today announced an agreement with Ikano Therapeutics, Inc. to obtain exclusive global rights to ITI-111, Ikano's nasal midazolam. Under terms of the agreement, Upsher-Smith will assume all further development, testing...
New Data Demonstrates Victoza® (liraglutide rDNA injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at On...
June 28, 2010 6:36 am | by Bio-Medicine.Org | CommentsORLANDO, Fla. , June 28 /- Poster 16LB -- Late-breaking Novo Nordisk (NVO) extension data presented today at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA) showed that once-daily Victoza ® in combination with metformin produced sustained and...
New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes
June 28, 2010 6:36 am | by Bio-Medicine.Org | CommentsPARSIPPANY, N.J. , June 28 /- Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a...
